Most Active Articles 2013-05-25T10:39:18.874-04:00 Business Exchange Business_Exchange@businessweek.com urn:com:businessweek:bx:topic:most-active:alzheimers Cathy Arnst carnst812 urn:com:businessweek:bx:article:2484603415981092690-c36f1a76a4397851dca122630292ba9a 2012-09-30T11:16:39.587-04:00

Could what we are eating be killing our brain? Could Alzheimer's be a type of diabetes?

Could what we are eating be killing our brain? Could Alzheimer's be a type of diabetes? http://www.alzheimersreadingroom.com/2012/09/is-alzheimers-type-3-diabetes.html Bob DeMarco bdemarco470 2 1 0 1 urn:com:businessweek:bx:article:7622315383133508002-0bfe261e78270781e55b0b43a210e06f 2013-04-12T21:23:05.339-04:00

Springhill Care Group Korea Free Alzheimer’s Training Available in all 50 States to Support Family Caregivers Alzheimer’s disease is a fatal, progressive and degenerative disease that destroys brain cells. It is the most common form of dementia. Alzheimer’s disease is not a normal part of aging. Symptoms include having difficulty remembering things, making decisions and performing everyday activities. These changes can affect the way a person feels and acts. There is currently no way to stop the disease, but research is improving the way provide care and will continue to search for a cure. Americans fear developing Alzheimer’s disease more than any other major life-threatening disease, including cancer, stroke, heart disease and diabetes according to OMAHA, Neb. – November 13, 2012 – Home Instead Senior Care®, the world’s leading provider of home care services for seniors, announced new survey results. More than 1,200 Americans was designed to gain perspective on the most pressing concerns associated with Alzheimer’s, including diagnosis and the difficulties of caring for a loved one with the disease, according to the survey of Marist Institute for Public Opinion. According to Jeff Huber, president and chief operating officer of Home Instead, Inc. “The survey confirmed what our franchise owners had been hearing from their clients and their families – the majority of Americans feel unprepared to care for a loved one diagnosed with Alzheimer’s. The need for support and education for these families is critical.” Additional survey highlights include: • Nearly two-thirds of Americans (63 percent) have had a personal experience with someone with Alzheimer’s and/or a serious memory loss problem. • 61 percent of Americans feel unprepared to care for a loved one diagnosed with the disease. • If diagnosed with the disease, Americans most fear the inability to care for oneself, and burdening others (68 percent); followed by losing memory of life and loved ones (32 percent). • A plurality of Americans – 44 percent – cites the illness as their most feared disease compared to 33 percent who cite cancer. • More than other generations, a majority of Americans over 65 years of age (the silent/greatest generation) – 56 percent – fear an Alzheimer’s diagnosis. • When asked if it would be harder to receive an Alzheimer’s diagnosis or care for someone with the disease, Americans are equally split down the middle, 50/50. READ MORE: http://news.springhillcaregroup.net/category/springhill-group-news/ Springhill Care Group Korea

Springhill Care Group Korea Free Alzheimer’s Training Available in all 50 States to Support Family Caregivers Alzheimer’s disease is a fatal, progressive and degenerative disease that destroys brain cells. It is the most common form of dementia. Alzheimer’s disease is not a normal part of aging. Symptoms include having difficulty remembering things, making decisions and performing everyday activities. These changes can affect the way a person feels and acts. There is currently no way to stop the disease, but research is improving the way provide care and will continue to search for a cure. Americans fear developing Alzheimer’s disease more than any other major life-threatening disease, including cancer, stroke, heart disease and diabetes according to OMAHA, Neb. – November 13, 2012 – Home Instead Senior Care®, the world’s leading provider of home care services for seniors, announced new survey results. More than 1,200 Americans was designed to gain perspective on the most pressing concerns associated with Alzheimer’s, including diagnosis and the difficulties of caring for a loved one with the disease, according to the survey of Marist Institute for Public Opinion. According to Jeff Huber, president and chief operating officer of Home Instead, Inc. “The survey confirmed what our franchise owners had been hearing from their clients and their families – the majority of Americans feel unprepared to care for a loved one diagnosed with Alzheimer’s. The need for support and education for these families is critical.” Additional survey highlights include: • Nearly two-thirds of Americans (63 percent) have had a personal experience with someone with Alzheimer’s and/or a serious memory loss problem. • 61 percent of Americans feel unprepared to care for a loved one diagnosed with the disease. • If diagnosed with the disease, Americans most fear the inability to care for oneself, and burdening others (68 percent); followed by losing memory of life and loved ones (32 percent). • A plurality of Americans – 44 percent – cites the illness as their most feared disease compared to 33 percent who cite cancer. • More than other generations, a majority of Americans over 65 years of age (the silent/greatest generation) – 56 percent – fear an Alzheimer’s diagnosis. • When asked if it would be harder to receive an Alzheimer’s diagnosis or care for someone with the disease, Americans are equally split down the middle, 50/50. READ MORE: http://news.springhillcaregroup.net/category/springhill-group-news/ Springhill Care Group Korea http://news.springhillcaregroup.net/category/springhill-group-news/ lush crushn lcrushn590 0 0 0 0 urn:com:businessweek:bx:article:885732876490544938-9c498b220c8a21f1a97c233f4e89fbde 2012-07-17T15:54:52.839-04:00

This is the first study to report long term stabilization of Alzheimer's symptoms over a period of 36 months.

This is the first study to report long term stabilization of Alzheimer's symptoms over a period of 36 months. http://www.alzheimersreadingroom.com/2012/07/is-gammagard-one-alzheimers-community.html Bob DeMarco bdemarco470 1 1 0 0 urn:com:businessweek:bx:article:8287544596009926160-c8da0d5cf671deeeb9027dbc6d9d9495 2012-07-14T12:46:25.014-04:00

If all three drugs fail and fail miserably the Alzheimer's community is in trouble. The pharmaceutical companies might give up. They might conclude that Alzheimer's cannot be treated effectively.

If all three drugs fail and fail miserably the Alzheimer's community is in trouble. The pharmaceutical companies might give up. They might conclude that Alzheimer's cannot be treated effectively. http://www.alzheimersreadingroom.com/2012/07/battleground-zero-for-new-alzheimers.html Bob DeMarco bdemarco470 3 3 0 0 urn:com:businessweek:bx:article:5285914002387150365-54d86d8a134c0e8d6a570fd4eece2434 2012-08-06T20:26:47.455-04:00

These clinical findings and the decision to discontinue the bapineuzumab IV program in patients with mild-to-moderate Alzheimer’s disease is another setback for the Alzheimer's Community.

These clinical findings and the decision to discontinue the bapineuzumab IV program in patients with mild-to-moderate Alzheimer’s disease is another setback for the Alzheimer's Community. http://www.alzheimersreadingroom.com/2012/08/Bapineuzumab-Pfizer-Results-Clinical-Trial.html Bob DeMarco bdemarco470 1 1 0 0 urn:com:businessweek:bx:article:15161444019773597739-c663c2ca92c4eaa43e9a5f212ec0e06c 2012-07-12T09:30:14.156-04:00

Scientists have assembled the most detailed chronology to date of the human brain’s long, slow slide into full-blown Alzheimer’s disease.

Scientists have assembled the most detailed chronology to date of the human brain’s long, slow slide into full-blown Alzheimer’s disease. http://www.alzheimersreadingroom.com/2012/07/timeline-established-for-brains-descent.html Bob DeMarco bdemarco470 1 1 0 0 urn:com:businessweek:bx:article:11198526337957198850-3e1f79ebc69b74bfbc6f6a761e1f8d54 2010-02-18T07:44:01.795-05:00

Many Alzheimer's researchers are targeting other potential causes [of Alzheimer's], like tau protein tangles and inflammation. They're also investigating drugs that treat other ailments. The most promising new dementia therapy in this vein is methylthioninium (Rember).....

Many Alzheimer's researchers are targeting other potential causes [of Alzheimer's], like tau protein tangles and inflammation. They're also investigating drugs that treat other ailments. The most promising new dementia therapy in this vein is methylthioninium (Rember)..... http://www.alzheimersreadingroom.com/2010/02/rember-methylene-blue-for-alzheimers.html Bob DeMarco bdemarco470 683 683 0 0 urn:com:businessweek:bx:article:17429740321201404263-1a721901c1ac16c723cefa841a238b48 2012-07-17T09:14:52.854-04:00

A team of scientists at the New York Stem Cell Foundation (NYSCF) Laboratory have developed a cell-based model of Alzheimer’s by reprogramming skin cells of Alzheimer’s patients to become brain cells.

A team of scientists at the New York Stem Cell Foundation (NYSCF) Laboratory have developed a cell-based model of Alzheimer’s by reprogramming skin cells of Alzheimer’s patients to become brain cells. http://www.alzheimersreadingroom.com/2012/07/new-model-of-alzheimers.html Bob DeMarco bdemarco470 2 2 0 0 urn:com:businessweek:bx:article:12343188842936027728-2ecdf93ce9a25a3f19ba5adf28b10ebf 2012-07-08T16:27:12.663-04:00

By 2015 to 2020, somewhere in there, there's a tipping point where our healthcare system will collapse under Alzheimer's alone.

By 2015 to 2020, somewhere in there, there's a tipping point where our healthcare system will collapse under Alzheimer's alone. http://www.alzheimersreadingroom.com/2012/01/are-we-near-tipping-point-in-alzheimers.html Bob DeMarco bdemarco470 3 3 0 0 urn:com:businessweek:bx:article:10482890605338722636-b9b6d115d21499e8e91fdde68cbb63ed 2011-12-15T07:55:13.765-05:00

The drug (J147) may be the first capable of halting mental decline associated with Alzheimer's disease. A new drug candidate may be the first capable of halting the devastating mental decline of Alzheimer's disease, based on the findings of a study published today in PLoS one.

The drug (J147) may be the first capable of halting mental decline associated with Alzheimer's disease. A new drug candidate may be the first capable of halting the devastating mental decline of Alzheimer's disease, based on the findings of a study published today in PLoS one. http://www.alzheimersreadingroom.com/2011/12/salk-scientists-develop-new-drug-that.html Bob DeMarco bdemarco470 14 14 0 0 urn:com:businessweek:bx:article:9340725379913922264-e2aa2fce5b9b9f84bb2fd28d44696ba5 2012-02-09T23:19:59.498-05:00

Neuroscientists at Case Western Reserve University School of Medicine have made a dramatic breakthrough in their efforts to find a cure for Alzheimer’s disease. The drug in question, Bexarotene has been approved for the treatment of cancer by the U.S. Food and Drug Administration for more than a decade.

Neuroscientists at Case Western Reserve University School of Medicine have made a dramatic breakthrough in their efforts to find a cure for Alzheimer’s disease. The drug in question, Bexarotene has been approved for the treatment of cancer by the U.S. Food and Drug Administration for more than a decade. http://www.alzheimersreadingroom.com/2012/02/cancer-drug-erases-alzheimers-symptoms.html Bob DeMarco bdemarco470 5 5 0 0 urn:com:businessweek:bx:article:14643092338151083079-f7df49d48ce8b006f064f932e3c86ce0 2012-07-02T17:59:18.780-04:00

Alzheimer’s has been affecting one in every eight elderly Americans since it was first publicly diagnosed in 1910. So much so that it has become the 6th leading cause of death in the US. Although, as technology grows and awareness...

Alzheimer’s has been affecting one in every eight elderly Americans since it was first publicly diagnosed in 1910. So much so that it has become the 6th leading cause of death in the US. Although, as technology grows and awareness... http://www.sobabyboomer.com/2012/07/alzheimers-research.html John Agno jagno444 4 4 0 0 urn:com:businessweek:bx:article:4983040041018046716-f2dcd6a1d9835e56596483a35e2ff9ee 2012-02-29T08:11:14.987-05:00

Legendary Texas Football Coach Darrell Royal and wife Edith positions DKR Fund as a ‘Texas game-changer’ in Alzheimer's disease care and research. Celebrities and business leaders lend their voice and support to cause.

Legendary Texas Football Coach Darrell Royal and wife Edith positions DKR Fund as a ‘Texas game-changer’ in Alzheimer's disease care and research. Celebrities and business leaders lend their voice and support to cause. http://www.alzheimersreadingroom.com/2012/02/darrell-k-royal-fund-for-alzheimers.html Bob DeMarco bdemarco470 0 0 0 0 urn:com:businessweek:bx:article:5524511650319261029-761c5d2808fc34ecb90c9a34ffe50d3c 2009-12-06T05:27:00.000-05:00

...and safe recovery of individuals with Alzheimer’s disease and other...

...and safe recovery of individuals with Alzheimer’s disease and other... http://www.i-newswire.com/birds-eye-global-tracking-announces/13632 272 272 0 0 urn:com:businessweek:bx:article:4954850250910004262-c08cfeea43f5aeb0c1cb2ca0e9f408a8 2012-01-10T21:06:02.661-05:00

Stem cell-based therapies offer potential new ways to treat diseases for which there is no current cure, including heart disease, the leading cause of death among U.S. adults. The unique ability of embryonic stem cells to transform ...

Stem cell-based therapies offer potential new ways to treat diseases for which there is no current cure, including heart disease, the leading cause of death among U.S. adults. The unique ability of embryonic stem cells to transform ... http://blog.assaydepot.com/dialing-in-on-americans-thoughts-on-stem-cell Neil Spencer nspencer445 3 3 0 0 urn:com:businessweek:bx:article:5067779122238359504-e216928a757c199535b2cada451b343f 2012-07-15T10:35:04.792-04:00

Results suggest varying brain activity may reduce the risk of Alzheimer's disease. Activity lingers longer in certain areas of the brain in those with Alzheimer's than it does in healthy people, Mayo Clinic researchers who created a map of the brain found.

Results suggest varying brain activity may reduce the risk of Alzheimer's disease. Activity lingers longer in certain areas of the brain in those with Alzheimer's than it does in healthy people, Mayo Clinic researchers who created a map of the brain found. http://www.alzheimersreadingroom.com/2012/07/mayo-brain-map-indicates-alzheimers.html Bob DeMarco bdemarco470 3 3 0 0 urn:com:businessweek:bx:article:5205917817059665950-c5dbd69d8a754c38628ee31a186c9365 2011-10-27T10:57:23.865-04:00

Sixty percent of persons living with Alzheimer's wander. The GPS tracking shoe could be the answer to this problem.

Sixty percent of persons living with Alzheimer's wander. The GPS tracking shoe could be the answer to this problem. http://www.alzheimersreadingroom.com/2011/10/gps-tracking-shoe-for-dementia-patients.html Bob DeMarco bdemarco470 6 6 0 0 urn:com:businessweek:bx:article:18253149287886674179-80ba5701608759435e13e487c0c7af65 2008-08-07T02:04:00.000-04:00

WASHINGTON, DC—Alzheimer's sufferers from across the nation marched on random buildings throughout Washington, D.C., Washington State, and Iowa...

WASHINGTON, DC—Alzheimer's sufferers from across the nation marched on random buildings throughout Washington, D.C., Washington State, and Iowa... http://www.shoutwire.com/comments/183199/Alzheimer_s_Sufferers_Demand_Cure_For_Pancakes 262 262 0 0 urn:com:businessweek:bx:article:9461275405195078232-aa0864c0fb6cae3eacabdfba06428b48 2012-08-02T15:06:07.361-04:00

It is almost like a cult, people extolling coconut oil as a treatment for Alzheimer's disease. In the article below Rudy Tanzi discusses the issue and offers possible explanations of the positive affect of coconut oil on Alzheimer's patients.

It is almost like a cult, people extolling coconut oil as a treatment for Alzheimer's disease. In the article below Rudy Tanzi discusses the issue and offers possible explanations of the positive affect of coconut oil on Alzheimer's patients. http://www.alzheimersreadingroom.com/2012/07/Alzheimers-Coconut-Oil-Antioxidants.html Bob DeMarco bdemarco470 1 1 0 0 urn:com:businessweek:bx:article:16087567978508504844-b2670d3fc226d133512cd18b593a44ce 2010-03-18T15:48:57.150-04:00

Johnson & Johnson took over development of bapineuzumab, when it bought Elan's Alzheimer’s program last year. Study results for bapineuzumab were originally forecast for release in 2010.

Johnson & Johnson took over development of bapineuzumab, when it bought Elan's Alzheimer’s program last year. Study results for bapineuzumab were originally forecast for release in 2010. http://www.alzheimersreadingroom.com/2010/03/johnson-johnson-jnj-bapineuzumab-more.html Bob DeMarco bdemarco470 90 90 0 0 urn:com:businessweek:bx:article:1008524954626265745-24fc9723bd8de2d522146b1bb85a4050 2011-07-18T10:08:30.382-04:00

"It appears that there may be a very high rate of cognitive impairment in these retired football players, compared to the general population," Randolph said. "These findings support the hypothesis that repetitive head trauma from many years of playing American football may result in diminished brain reserve, and lead to the earlier expression of age-related neurodegenerative diseases such as MCI and Alzheimer's. However, additional studies are necessary to confirm this conclusion. These results should be considered preliminary."

"It appears that there may be a very high rate of cognitive impairment in these retired football players, compared to the general population," Randolph said. "These findings support the hypothesis that repetitive head trauma from many years of playing American football may result in diminished brain reserve, and lead to the earlier expression of age-related neurodegenerative diseases such as MCI and Alzheimer's. However, additional studies are necessary to confirm this conclusion. These results should be considered preliminary." http://www.alzheimersreadingroom.com/2011/07/nfl-football-players-maybe-more.html Bob DeMarco bdemarco470 7 7 0 0 urn:com:businessweek:bx:article:13000285679543334942-ff4ef2a128b22ea26d8fbd9f5e8e0c84 2011-11-15T12:01:41.136-05:00

I am witnessing the dawn of a new age of Alzheimers disease, an age that will be marked by the end of Alzheimers disease. A world without Alzheimers disease holds great promise to reduce the suffering of millions of patients and their families, but it also presents perils.

I am witnessing the dawn of a new age of Alzheimers disease, an age that will be marked by the end of Alzheimers disease. A world without Alzheimers disease holds great promise to reduce the suffering of millions of patients and their families, but it also presents perils. http://www.alzheimersreadingroom.com/2011/11/promises-and-perils-of-end-of.html Bob DeMarco bdemarco470 3 3 0 0 urn:com:businessweek:bx:article:17994611907626411978-615078f7f818c4c441bd43346cd083ae 2010-11-10T16:18:22.656-05:00

"For many older adults, cognitive impairment contributes to loss of independence, decreased quality of life and increased health care costs," the authors write. "While the public health impact of cognitive impairment is clear, this condition is often under-recognized. A simple, rapid cognitive assessment instrument is therefore a valuable tool for use in both clinical and research settings."

"For many older adults, cognitive impairment contributes to loss of independence, decreased quality of life and increased health care costs," the authors write. "While the public health impact of cognitive impairment is clear, this condition is often under-recognized. A simple, rapid cognitive assessment instrument is therefore a valuable tool for use in both clinical and research settings." http://www.alzheimersreadingroom.com/2010/11/alzheimers-disease-sweet-16-test-may-be.html Bob DeMarco bdemarco470 42 42 0 0 urn:com:businessweek:bx:article:7753625365798869965-767c8c500fd98a8e07f7f7501a929b9b 2011-09-06T16:01:49.720-04:00

Donepezil is marketed under the brand name Aricept by its developer Eisai (TSE) and partner Pfizer (PFE). You can now buy a one year supply of Donepezil for $109.00. This time last year you might have expected to pay $3,000.00 or more for a one year supply.

Donepezil is marketed under the brand name Aricept by its developer Eisai (TSE) and partner Pfizer (PFE). You can now buy a one year supply of Donepezil for $109.00. This time last year you might have expected to pay $3,000.00 or more for a one year supply. http://www.alzheimersreadingroom.com/2011/09/donepezil-aricept-price-falls-by-90.html Bob DeMarco bdemarco470 8 8 0 0 urn:com:businessweek:bx:article:6494014753478693297-615c3fb434cf8e80fea0544fcc94c1fc 2011-10-16T10:37:32.923-04:00

In this video Deepak Chopra talks to Dr. Rudy Tanzi about his groundbreaking research project, the Alzheimer's Genome Project, how gaining a better understanding of Alzheimer's disease leads to better treatments and a possible cure, and the important support of Cure Alzheimer's Fund in his research efforts. If you take the time to watch and listen to this video you will gain a good understanding of Alzheimer's..

In this video Deepak Chopra talks to Dr. Rudy Tanzi about his groundbreaking research project, the Alzheimer's Genome Project, how gaining a better understanding of Alzheimer's disease leads to better treatments and a possible cure, and the important support of Cure Alzheimer's Fund in his research efforts. If you take the time to watch and listen to this video you will gain a good understanding of Alzheimer's.. http://www.alzheimersreadingroom.com/2011/04/deepak-chopra-and-rudy-tanzi-discuss.html Bob DeMarco bdemarco470 3 3 0 0